Gold compounds in medicine: Potential anti-tumour agents

Abstract

An overview of the use of gold drugs in the alleviation of the symptoms associated with the debilitating disease rheumatoid arthritis (RA) is presented. Other potential therapies based on gold compounds, such as against parasitic diseases, HIV and asthma are summarised. The development of gold compounds as novel anti-tumour agents is also described. Compounds containing gold(I), as utilised in the treatment of RA, and gold(III), show exciting potential in this regard, there being some very potent compounds targeting biological targets, such as DNA, and displaying selectivity in their cytotoxic profiles. In conclusion, very real potential exists for the development of anti-tumour agents based on gold.

References

  1. 1

    W.F. Kean, F. Forestier, Y. Kassam, W.W Buchanan, P.J. Rooney,Semin. Arthritis Rheum. 1985,14, 180

    Article  CAS  Google Scholar 

  2. 2

    H. Zhao, Y. Ning,Gold Bull. 2001,34, 24

    Article  CAS  Google Scholar 

  3. 3

    e.g. (a) A.J. Lewis and D.T. Walz,Prog. Med. Chem. 1982,19, 1; (b) E.R.T. Tiekink, M.W. Whitehouse, in G. Berthon (Ed) Handbook of Metal-Ligand Interactions in Biological Fluids. Vol. 2. Marcel Dekker (New York), 1995, 1266

    Article  CAS  Google Scholar 

  4. 4

    e.g. E.R.T. Tiekink,Crit. Rev. Oncol. Hematl. 2002,42, 225

    Article  Google Scholar 

  5. 5

    e.g. T. Okada, B.K. Patterson, S.-Q. Ye, M.E. Gurney,Virology, 1993,192, 631

    Article  CAS  Google Scholar 

  6. 6

    M. Navarro, H. Pérez, R.A. Sánchez-Delgado,J. Med. Chem. 1997,40, 1937

    Article  CAS  Google Scholar 

  7. 7

    M. Muranaka, T. Miyamoto, T. Shida, J. Kabe, S. Makino, H. Okumura, K. Takeda, S. Suzuki, Y. Horiuchi,Ann. Allergy, 1978,40, 132

    CAS  Google Scholar 

  8. 8

    H. Ruben, A. Zalkin, M.O. Faltens, D.H. Templeton,Inorg. Chem. 1974,13, 1836

    Article  CAS  Google Scholar 

  9. 9

    DIAMOND, Visual Crystal Structure Information System, Version 2.1e, CRYSTAL IMPACT, Postfach 1251, D-53002 Bonn, Germany, 2002

  10. 10

    R. Bau,J. Am. Chem. Soc. 1998,120, 9380

    Article  CAS  Google Scholar 

  11. 11

    D.T. Hill, B.M. Sutton,Cryst. Struct. Commun, 1980,9, 679

    CAS  Google Scholar 

  12. 12

    C.F. Shaw III,Chem. Rev. 1999,99, 2589

    Article  CAS  Google Scholar 

  13. 13

    C.F. Shaw III,Topics Biol. Inorg. Chem. 1999,2, 187

    CAS  Google Scholar 

  14. 14

    P.D. Cookson, E.R.T. Tiekink, M. W. Whitehouse,Aust. J. Chem. 1994,47, 577

    Article  CAS  Google Scholar 

  15. 15

    M.W. Whitehouse, P.D. Cookson, G. Siasios, E.R.T. Tiekink,Metal-Based Drugs, 1998,5, 245

    Article  CAS  Google Scholar 

  16. 16

    K. Tepperman, Y. Zhang, P.W. Roy, R. Floyd, Z. Zhao, J.G. Dorsey, R.C. Elder,Metal-Based Drugs, 1994,1, 433

    Article  CAS  Google Scholar 

  17. 17

    C.F. Shaw III, Uses of Inorganic Chemistry in Medicine, N. P. Farrell, (Ed), Royal Society of Chemistry, 1999, 26

  18. 18

    K.E. Traber, H. Okamoto, C. Kurono, M. Baba, C. Saliou, T. Soji, L. Packer, T. Okamoto,Int. Immunol. 1999,11, 143

    Article  CAS  Google Scholar 

  19. 19

    K. Yamaguchi, H. Ushijima, M. Hisano, Y. Inoue, T. Shimamura, T. Hirano, E. G. W. Muller,Microbiol. Immunol. 2001,45, 549

    CAS  Google Scholar 

  20. 20

    M. Adachi, H. Sato, T. Takahashi,Ther. Res. 1986,5, 796; CAN 106:168349

    CAS  Google Scholar 

  21. 21

    A.C. Falcao, M.J. Rocha, A.M. Almeida, M.M. Caramona,J. Clin. Pharma. Ther. 2000,25, 191

    Article  CAS  Google Scholar 

  22. 22

    M.S. Dykewicz,Allerg. Asth. Proc. 2001,22, 11

    Article  CAS  Google Scholar 

  23. 23

    A.M. Vignola, P. Chanez, J. Bousquet, inLung Biology in Health and Disease, 2001,159, 575

    CAS  Google Scholar 

  24. 24

    A.J. Frew, M.J. Plummeridge,J. Allergy Clin. Immuno. 2001,108, 3

    Article  CAS  Google Scholar 

  25. 25

    M. Navarro, E.J. Cisneros-Fajardo, T. Lehmann, R.A. Sánchez-Delgardo, R. Atencio, P. Silva, R. Lira, J.A. Urbina,Inorg. Chem. 2001,40, 6879

    Article  CAS  Google Scholar 

  26. 26

    J.F. Fries, D. Bloch, P. Spitz, D.M. Mitchell,Am. J. Med. 1988, 85 (Suppl. 4A), 56

    Google Scholar 

  27. 27

    C.K. Mirabelli, R.K. Johnson, D. T. Hill, L. F. Faucette, G.R. Girard, G.Y. Kuo, C.-M. Sung, S.T. Crooke,J. Med. Chem. 1986,29, 218

    Article  CAS  Google Scholar 

  28. 28

    C.K. Mirabelli, B.D. Jensen, M.R. Mattern, C.-M. Sung, S.-M. Mong, D.T. Hill, S.W. Dean, P.S. Schein, R.K. Johnson, S.T. Crooke,Anticancer Drug Des. 1986,1, 223

    CAS  Google Scholar 

  29. 29

    C.K. Mirabelli, D.T. Hill, L. F. Faucette, F.L. McCabe, G.R. Girard, D.B. Bryan, B.M. Sutton, J. O'Leary Bartus, S.T. Crooke, R.K. JohnsonJ. Med. Chem. 1987,30, 2181

    Article  CAS  Google Scholar 

  30. 30

    S.J. Berners-Price, M.A. Mazid, P.J. Sadler,J. Chem. Soc., Dalton Trans, 1984, 969

  31. 31

    M.J. McKeage, L. Maharaj, S.J. Berners-Price,Coord. Chem. Rev. 2002,232, 127

    Article  CAS  Google Scholar 

  32. 32

    E.R.T. Tiekink, P.D. Cookson, B.M. Linahan, L.K. Webster,Metal-Based Drugs, 1994,1, 299

    Article  CAS  Google Scholar 

  33. 33

    L.K. Webster, S. Rainone, E. Horn, E.R.T. Tiekink,Metal-Based Drugs, 1996,3, 63

    Article  CAS  Google Scholar 

  34. 34

    D. Crump, G. Siasios, E.R.T. Tiekink,Metal-Based Drugs, 1999,6, 361.

    Article  CAS  Google Scholar 

  35. 35

    E.R.T. Tiekink,Metals Ions Biol. Med., 1996,4, 693

    Google Scholar 

  36. 36

    D. de Vos, P. Clements, S.M. Pyke, D.R. Smyth and E.R.T. Tiekink,Metal-Based Drugs, 1999,6, 31

    Article  Google Scholar 

  37. 37

    D. de Vos, D.R. Smyth, E.R.T. Tiekink,Metal-Based Drugs, 2001,8, 303

    Article  Google Scholar 

  38. 38

    E.R.T. Tiekink,Bioinorg. Chem. Appln, 2003,1, 53

    Article  CAS  Google Scholar 

  39. 39

    (a)S. Carotti, A. Guerri, T. Mazzei, L. Messori, E. Mini, P. Orioli,Inorg Chim Acta, 1998,81, 90; (b) S. Carotti, G. Marcon, M. Marussich, T. Mazzei, L. Messori, E. Mini, P. Orioli,Chem.-Biol, Inter. 2000,125, 29

    Article  Google Scholar 

  40. 40

    e.g. A. Moustatih, A. Garnier-Suillerot,J. Med. Chem. 1989,32, 1426.

    Article  CAS  Google Scholar 

  41. 41

    e.g. L. Messori, F. Abbate, G. Marcon, P. Orioli, M. Fontani, E. Mini, T. Mazzei, S. Carotti, T. O'Connell, P. Zanello,J. Med. Chem. 2000,43, 3541

    Article  CAS  Google Scholar 

  42. 42

    e.g. (a) R.V. Parish,Metal-Based Drugs, 1999,6, 271; (b) M.B. Dinger, W. Henderson,J. Organomet. Chem. 1998,560, 233

    Article  CAS  Google Scholar 

  43. 43

    C.-M. Che, R.W.-Y. Sun, W.-Y. Yu, C.-B. Ko, N. Zhu, H. Sun,Chem Commun, 2003, 1718

  44. 44

    T. Yang, C. Tu, J. Zhang, L. Liu, X. Zhang, Q. Liu, J. Ding, Q. Xu, Z. Guo,Dalton Trans, 2003, 3419

  45. 45

    F. Caruso, M. Rossi, J. Tanski, C. Pettinari, F. Marchetti,J. Med. Chem. 2003,46, 1737

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.

About this article

Cite this article

Tiekink, E.R.T. Gold compounds in medicine: Potential anti-tumour agents. Gold Bull 36, 117–124 (2003). https://doi.org/10.1007/BF03215502

Download citation

Keywords

  • Human Immunodeficiency Virus
  • Auranofin
  • Gold Compound
  • Gold Bulletin
  • Sodium Aurothiomalate